You have 9 free searches left this month | for more free features.

Head and Neck Tumors

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumors, Head Neck Cancer Trial in Shijiazhuang (SYH2051 tablets, Intensity-Modulated Radiation Therapy (IMRT))

Recruiting
  • Solid Tumors
  • Head and Neck Cancer
  • SYH2051 tablets
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Shijiazhuang, Hebei, China
    Clinical Trials Information Group
Aug 21, 2023

Head and Neck Squamous Cell Carcinoma Trial (HS-20093)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Aug 17, 2023

Head and Neck Tumors Trial (intraoperative navigation and creation of tumor resection maps)

Not yet recruiting
  • Head and Neck Tumors
  • intraoperative navigation and creation of tumor resection maps
  • (no location specified)
Jan 2, 2023

Head and Neck Tumors Trial in Nanjing (Tislelizumab, Paclitaxel (albumin-bound type), Cisplatin, 5-FU)

Recruiting
  • Head and Neck Tumors
  • Tislelizumab, Paclitaxel (albumin-bound type), Cisplatin, 5-FU
  • Nanjing, Jiangsu, China
    Department of Oncology, Drum Tower Hospital, Nanjing University
Feb 24, 2023

Early Postoperative Mobilization in Recovery of Oral Head and

Completed
  • Length of Hospital Stay
  • Early Mobilization
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital
May 1, 2023

Objective Response Rate Trial in Wuhan (GM-CSF)

Recruiting
  • Objective Response Rate
  • Wuhan, Hubei, China
    Renmin Hospital of Wuhan University
Feb 25, 2023

Head and Neck Tumors, Malignant Tumor of Vertebral Column Trial in Boston (Cryoablation, Biopsy)

Completed
  • Head and Neck Neoplasms
  • Malignant Neoplasm of Vertebral Column
  • Cryoablation
  • Biopsy
  • Boston, Massachusetts
  • +1 more
Jul 19, 2022

Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Breast Cancer
  • +4 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 19, 2023

Head and Neck Tumors Trial in Ghent (GRID radiotherapy)

Terminated
  • Head and Neck Tumors
  • GRID radiotherapy
  • Ghent, Belgium
    University Hospital Ghent
Dec 15, 2022

Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma Trial (LSTA1,

Not yet recruiting
  • Esophageal Cancer
  • +9 more
  • (no location specified)
Feb 2, 2023

Carcinoma, Squamous Cell of Head and Neck, NSCLC, Ovarian Tumors Trial (disitamab vedotin)

Not yet recruiting
  • Carcinoma, Squamous Cell of Head and Neck
  • +3 more
  • disitamab vedotin
  • (no location specified)
Aug 15, 2023

Colorectal Tumors, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial (SGN-EGFRd2)

Not yet recruiting
  • Colorectal Neoplasms
  • +3 more
  • (no location specified)
Aug 1, 2023

Solid Tumor, EGFR Amplification Trial in Tianjin (Nimotuzumab)

Recruiting
  • Solid Tumor
  • EGFR Amplification
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Aug 28, 2023

Tumors of Head, Neck, Thorax, Abdomen, Pelvis and Extremities.

Active, not recruiting
  • Radiation Therapy Complication
  • +2 more
  • Spatially Fractionated Radiation (GRID) Therapy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 31, 2022

Malignant Tumor in the Head and Neck, Metastatic Malignant Tumor in the Head and Neck Trial in Seattle (other, procedure, drug)

Not yet recruiting
  • Malignant Neoplasm in the Head and Neck
  • Metastatic Malignant Neoplasm in the Head and Neck
  • Iodixanol
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2022

3D-PCT Combined With CT-guided Radioactive I-125 Seed

Recruiting
  • Malignant Tumor of Head and/or Neck
  • Radioactive Iodine-125 Seeds Implantation
  • Beijing, China
    Department of Radiation Oncology of Peking university third hosp
Jul 18, 2022

Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer Trial in Boston (Palbociclib, Gedatolisib)

Recruiting
  • Lung Cancer Squamous Cell
  • +3 more
  • Boston, Massachusetts
  • +2 more
Jan 9, 2023

Head and Neck Cancer in Children: A Retrospective Study

Recruiting
  • Head and Neck Neoplasms
  • +4 more
    • Assiut, Egypt
      Assiut University
    Apr 11, 2022

    Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

    Not yet recruiting
    • Carcinoma
    • +7 more
    • XNW5004
    • Pembrolizumab 25 mg/mL Solution for Injection
    • (no location specified)
    Aug 31, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Experimental: Stage 1L: HLX10 Plus HLX07, Experimental: Stage 1H: HLX10

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Experimental: Stage 1L: HLX10 Plus HLX07
    • Experimental: Stage 1H: HLX10 Plus HLX07
    • Shanghai, Shanghai, China
      Shanghai Henlius Biotech Inc.
    May 5, 2022

    Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma Trial in San Antonio (SRF114)

    Recruiting
    • Advanced Solid Tumor
    • Head and Neck Squamous Cell Carcinoma
    • San Antonio, Texas
      START- San Antonio
    Jan 2, 2023

    Unknown Primary Tumors, Oropharynx Cancer Trial in Groningen (Detection of lesions using fluorescence molecular imaging)

    Recruiting
    • Unknown Primary Tumors
    • Oropharynx Cancer
    • Detection of lesions using fluorescence molecular imaging
    • Groningen, Netherlands
      University Medical Center Groningen
    Oct 20, 2023

    Molecular and Genomic Profiling of Head and Neck Tumors

    Recruiting
    • Head and Neck Neoplasms
      • Bronx, New York
        Stelby Augustine
      Feb 17, 2022

      Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck Squamous-cell Carcinoma, Locally Advanced Cutaneous

      Active, not recruiting
      • Recurrent Head and Neck Squamous Cell Carcinoma
      • +3 more
      • 200 mg Pembrolizumab
      • +2 more
      • Miami, Florida
      • +6 more
      Jan 9, 2023

      Head Neck Cancer Trial in Guangzhou (Jeksung combined with anti-radiation spray)

      Recruiting
      • Head and Neck Cancer
      • Jeksung combined with anti-radiation spray
      • Guangzhou, Guangdong, China
        Yu Zeng
      May 4, 2022